Agilent Technologies Total Depreciation and Amortization - Cash Flow 2010-2025 | A
Agilent Technologies annual/quarterly total depreciation and amortization - cash flow history and growth rate from 2010 to 2025. Total depreciation and amortization - cash flow can be defined as the total amount of depreciation and amortization listed on the Cash Flows Statement
- Agilent Technologies total depreciation and amortization - cash flow for the quarter ending April 30, 2025 was $145M, a 16% increase year-over-year.
- Agilent Technologies total depreciation and amortization - cash flow for the twelve months ending April 30, 2025 was $662M, a 0.75% decline year-over-year.
- Agilent Technologies annual total depreciation and amortization - cash flow for 2024 was $0.257B, a 5.17% decline from 2023.
- Agilent Technologies annual total depreciation and amortization - cash flow for 2023 was $0.271B, a 14.51% decline from 2022.
- Agilent Technologies annual total depreciation and amortization - cash flow for 2022 was $0.317B, a 1.25% decline from 2021.
| Agilent Technologies Annual Total Depreciation and Amortization - Cash Flow (Millions of US $) |
|
|---|---|
| 2024 | $257 |
| 2023 | $271 |
| 2022 | $317 |
| 2021 | $321 |
| 2020 | $308 |
| 2019 | $238 |
| 2018 | $210 |
| 2017 | $212 |
| 2016 | $246 |
| 2015 | $253 |
| 2014 | $362 |
| 2013 | $372 |
| 2012 | $301 |
| 2011 | $253 |
| 2010 | $202 |
| 2009 | $162 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $33.923B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.564B | 27.96 |
| Boston Scientific (BSX) | United States | $154.721B | 38.73 |
| Stryker (SYK) | United States | $149.011B | 31.16 |
| EssilorLuxottica (ESLOY) | France | $125.383B | 0.00 |
| Medtronic (MDT) | Ireland | $110.530B | 15.67 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.919B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.856B | 26.72 |
| ResMed (RMD) | United States | $37.567B | 28.22 |
| GE HealthCare Technologies (GEHC) | United States | $34.277B | 16.27 |
| Terumo (TRUMY) | Japan | $27.568B | 35.81 |
| Koninklijke Philips (PHG) | Netherlands | $23.187B | 16.27 |
| Insulet (PODD) | United States | $21.804B | 85.59 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.151B | 11.66 |
| Baxter (BAX) | United States | $15.652B | 11.69 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.231B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.625B | 23.06 |
| Lantheus Holdings (LNTH) | United States | $5.586B | 14.09 |
| Prestige Consumer Healthcare (PBH) | United States | $4.010B | 17.91 |
| Perrigo (PRGO) | Ireland | $3.653B | 9.26 |
| Haemonetics (HAE) | United States | $3.592B | 16.36 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.330B | 27.68 |
| ICU Medical (ICUI) | United States | $3.216B | 23.72 |
| GN Store Nord (GNNDY) | Denmark | $2.307B | 19.11 |
| QuidelOrtho (QDEL) | United States | $1.941B | 13.35 |
| LeMaitre Vascular (LMAT) | United States | $1.862B | 41.62 |
| AtriCure (ATRC) | United States | $1.628B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.271B | 12.90 |
| Acuren (TIC) | United States | $1.252B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.120B | 25.19 |
| Neogen (NEOG) | United States | $1.040B | 13.31 |
| BioLife Solutions (BLFS) | United States | $1.020B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.018B | 13.02 |
| Kestra Medical Technologies (KMTS) | United States | $0.919B | 0.00 |
| InMode (INMD) | Israel | $0.889B | 8.96 |
| CeriBell (CBLL) | United States | $0.697B | 0.00 |
| Owens & Minor (OMI) | United States | $0.644B | 5.34 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.606B | 0.00 |
| Evolus (EOLS) | United States | $0.600B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.551B | 0.00 |
| Valneva SE (VALN) | France | $0.489B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.465B | 0.00 |
| Surmodics (SRDX) | United States | $0.416B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.415B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.352B | 12.94 |
| SNDL (SNDL) | Canada | $0.328B | 0.00 |
| Quanterix (QTRX) | United States | $0.328B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.283B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.273B | 23.03 |
| Cerus (CERS) | United States | $0.260B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.252B | 0.00 |
| ZimVie (ZIMV) | United States | $0.251B | 11.39 |
| Cresco Labs (CRLBF) | United States | $0.250B | 0.00 |
| Brainsway (BWAY) | Israel | $0.248B | 65.50 |
| Aurora Cannabis (ACB) | Canada | $0.239B | 71.00 |
| Biote (BTMD) | United States | $0.234B | 6.58 |
| Canopy Growth (CGC) | Canada | $0.228B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.226B | 0.00 |
| Omeros (OMER) | United States | $0.195B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.192B | 0.00 |
| Organigram Global (OGI) | Canada | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 14.93 |
| Verano Holdings (VRNOF) | United States | $0.175B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.136B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.120B | 14.79 |
| Jin Medical (ZJYL) | China | $0.102B | 0.00 |
| Veru (VERU) | United States | $0.096B | 0.00 |
| Fonar (FONR) | United States | $0.089B | 11.54 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.083B | 0.00 |
| MacroGenics (MGNX) | United States | $0.080B | 0.00 |
| Zynex (ZYXI) | United States | $0.079B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.079B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.065B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| Nephros (NEPH) | United States | $0.045B | 60.57 |
| United-Guardian (UG) | United States | $0.038B | 13.18 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |